Merriman Wealth Management LLC acquired a new stake in shares of UnitedHealth Group Inc (NYSE:UNH) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 1,517 shares of the healthcare conglomerate’s stock, valued at approximately $372,000.
A number of other large investors have also modified their holdings of the stock. Argent Trust Co increased its position in shares of UnitedHealth Group by 8.3% in the fourth quarter. Argent Trust Co now owns 13,911 shares of the healthcare conglomerate’s stock worth $3,066,000 after purchasing an additional 1,061 shares during the last quarter. Alps Advisors Inc. bought a new position in shares of UnitedHealth Group in the first quarter worth approximately $280,000. First Long Island Investors LLC increased its position in shares of UnitedHealth Group by 1.1% in the first quarter. First Long Island Investors LLC now owns 26,401 shares of the healthcare conglomerate’s stock worth $5,650,000 after purchasing an additional 300 shares during the last quarter. Capital Advisors Inc. OK increased its position in shares of UnitedHealth Group by 60.9% in the first quarter. Capital Advisors Inc. OK now owns 72,298 shares of the healthcare conglomerate’s stock worth $15,472,000 after purchasing an additional 27,359 shares during the last quarter. Finally, KHP Capital LLC bought a new position in shares of UnitedHealth Group in the first quarter worth approximately $164,000. Hedge funds and other institutional investors own 85.35% of the company’s stock.
In other UnitedHealth Group news, CEO Steven H. Nelson sold 8,142 shares of the stock in a transaction on Thursday, September 13th. The stock was sold at an average price of $265.00, for a total value of $2,157,630.00. Following the completion of the transaction, the chief executive officer now owns 22,496 shares in the company, valued at $5,961,440. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction on Wednesday, August 1st. The shares were sold at an average price of $254.79, for a total value of $3,821,850.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 94,745 shares of company stock valued at $24,995,290. 0.87% of the stock is owned by corporate insiders.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share for the quarter, beating analysts’ consensus estimates of $3.04 by $0.10. The firm had revenue of $56.09 billion during the quarter, compared to analyst estimates of $56.10 billion. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The business’s quarterly revenue was up 12.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.46 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Inc will post 12.72 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 18th. Investors of record on Friday, September 7th were issued a dividend of $0.90 per share. The ex-dividend date of this dividend was Thursday, September 6th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.34%. UnitedHealth Group’s dividend payout ratio is presently 35.75%.
Several research analysts recently weighed in on the stock. Jefferies Financial Group upped their price objective on shares of UnitedHealth Group from $270.00 to $311.00 and gave the stock a “buy” rating in a research report on Wednesday, October 3rd. ValuEngine upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday, October 2nd. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $299.00 price objective on the stock in a research report on Tuesday, September 25th. Raymond James upped their price objective on shares of UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a research report on Monday, September 24th. Finally, Cowen started coverage on shares of UnitedHealth Group in a research report on Monday, September 17th. They issued an “outperform” rating and a $308.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating, twenty-two have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $278.61.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Trading Strategy Examples and Plans
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.